Insulin-like growth factor 1 receptor antagonist for regulating body weight and fat

摘要

The invention is directed to the use of insulin-like growth factor receptor antagonists for treatment of obesity. The IGF-IR antagonists are administered alone or in combination with other anti-obesity drugs.